SPECIALTIES:  CANCER & BLOOD DISORDERS

Dr. Plant is currently an attending physician in neuro-oncology at Ann and Robert H. Lurie Children’s Hospital of Chicago and Assistant Professor at Northwestern University Feinberg School of Medicine with a research focus on translational research and early clinical trial development for pediatric brain tumors. Currently, brain tumors are the second most common cancer diagnosis in children and the leading cause of cancer-related death in all pediatric age groups. Many children diagnosed with malignant brain tumors face a dismal prognosis at diagnosis with minimal effective treatments available. Early clinical trial development and translational research is crucial to the improvement of outcomes in pediatric neuro-oncology. Dr. Plant spent her fellowship research years in the laboratories of Glenn Dranoff, MD PhD and Jerome Ritz, MD at Dana Farber Cancer Institute focusing on immunophenotyping of pediatric brain tumors and biologic correlates of immunotherapy clinical trials. Dr. Plant has completed extra training in translational research including the Program for Clinical Effectiveness at the Harvard School of Public Health and the Markers in Cancer Course in Bethesda, MD May 2016. Dr. Plant was awarded a K12 NCI grant for translational research in nervous system tumors and was the recipient of the Stahl Family Foundation grant for early phase clinical trials in immunotherapy for pediatric neuro-oncology. She is also the first inaugural 2020 A.M. Khokhar Research Scholar award recipient and the first inaugural 2020 Will Irwin Memorial Fund Researcher. Dr. Plant is currently conducting an investigator-initiated phase 1/2 clinical trial using combination immunotherapy for diffuse intrinsic pontine glioma, a universally fatal disease. The trial combines a novel neo-antigen heat shock protein vaccine known as rHSC-DIPGVax in combination with anti-PD1 and anti-CTLA4 checkpoint blockade. The focus of Dr. Plant’s career is developing and running early phase clinical trials based on translational research in the area of pediatric neuro-oncology with a specific interest in immunotherapy.

Discuss With Your Physician

Anyone participating in a clinical trial should know as much as possible about what is being studied, what risks are involved and what potential benefits may be gained before deciding to enroll.  If you are interested in participating in a clinical trial, please talk to your physician first.

Print, save, or email this page to your physician to discuss at your next visit

December 3, 2024

November 29, 2023

Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe

• Presentation titled “Re-186 Radiolabelled NanoLiposomes for Rare Brain and Spinal Cord Tumors”

June 8, 2023

Plus Therapeutics Announces Participation at Upcoming SNO Pediatric Conference and SNMMI Annual Meeting

• Plus Therapeutics announced it will exhibit at both the Society for NeuroOncology’s (SNO) Pediatric Conference, taking place June 22-24, 2023 in Washington, D.C., and the Society of Nuclear Medicine & Molecular Imaging’s (SNMMI) Annual Meeting, taking place June 24-27, 2023 in Chicago, Illinois.

August 21, 2021

Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer

June 10, 2021

Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference

Note:  all external links

• American Brain Tumor Association
• American Cancer Society
• Brain Tumor Network
• Dictionary of Cancer Terms
• End Brain Cancer Initiative
• MedlinePlus (NIH)
• National Brain Tumor Society
• National Cancer Institute
• National Comprehensive Cancer Network
• Support Groups Listing
• The Brain Tumour Charity
• Trial Connect
• VirtualTrials.com
• Voices Against Brain Cancer